Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

van Dorp, Jeroen; Pipinikas, Christodoulos; Suelmann, Britt B. M.; Mehra, Niven; van Dijk, Nick; Marsico, Giovanni; van Montfoort, Maurits L.; Hackinger, Sophie; Braaf, Linde M.; Amarante, Tauanne; van Steenis, Charlaine; McLay, Kirsten; Daletzakis, Antonios; van den Broek, Daan; van de Kamp, Maaike W.; Hendricksen, Kees; de Feijter, Jeantine M.; Boellaard, Thierry N.; Meijer, Richard P.; van der Heijden, Antoine G.; Rosenfeld, Nitzan; van Rhijn, Bas W. G.; Jones, Greg; van der Heijden, Michiel S.

doi:10.1038/s41591-023-02500-7

Download PDF

Author Correction
Published: 17 July 2023

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Jeroen van Dorp ORCID: orcid.org/0000-0002-1395-612X^1,2^na1,
Christodoulos Pipinikas³^na1,
Britt B. M. Suelmann^2,4,
Niven Mehra^2,5,
Nick van Dijk ORCID: orcid.org/0000-0001-5115-5086^2,6,
Giovanni Marsico³,
Maurits L. van Montfoort^2,7,
Sophie Hackinger³,
Linde M. Braaf⁸,
Tauanne Amarante³,
Charlaine van Steenis⁹,
Kirsten McLay³,
Antonios Daletzakis¹⁰,
Daan van den Broek¹¹,
Maaike W. van de Kamp^2,12,
Kees Hendricksen^2,12,
Jeantine M. de Feijter^2,6,
Thierry N. Boellaard^2,13,
Richard P. Meijer^2,14,
Antoine G. van der Heijden^2,15,
Nitzan Rosenfeld^3,16,17,
Bas W. G. van Rhijn^2,12,18,
Greg Jones³^na2 &
…
Michiel S. van der Heijden ORCID: orcid.org/0000-0002-4407-7881^2,6^na2

Nature Medicine volume 30, page 304 (2024)Cite this article

1370 Accesses
4 Citations
1 Altmetric
Metrics details

Subjects

The Original Article was published on 02 February 2023

Correction to: Nature Medicine https://doi.org/10.1038/s41591-022-02199-y. Published online 2 February 2023.

In the version of this article initially published, the first name of Antoine G. van der Heijden was misspelled as “Toine” and has now been corrected in the HTML and PDF versions of the article.

Author information

These authors contributed equally: Jeroen van Dorp, Christodoulos Pipinikas.
These authors jointly supervised this work: Greg Jones, Michiel S. van der Heijden.

Authors and Affiliations

Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands
Jeroen van Dorp
Dutch Uro-Oncology Study Group, Bilthoven, The Netherlands
Jeroen van Dorp, Britt B. M. Suelmann, Niven Mehra, Nick van Dijk, Maurits L. van Montfoort, Maaike W. van de Kamp, Kees Hendricksen, Jeantine M. de Feijter, Thierry N. Boellaard, Richard P. Meijer, Antoine G. van der Heijden, Bas W. G. van Rhijn & Michiel S. van der Heijden
Inivata Ltd., Babraham Research Park, Cambridge, UK
Christodoulos Pipinikas, Giovanni Marsico, Sophie Hackinger, Tauanne Amarante, Kirsten McLay, Nitzan Rosenfeld & Greg Jones
Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Britt B. M. Suelmann
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
Niven Mehra
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Nick van Dijk, Jeantine M. de Feijter & Michiel S. van der Heijden
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Maurits L. van Montfoort
Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands
Linde M. Braaf
Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands
Charlaine van Steenis
Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands
Antonios Daletzakis
Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands
Daan van den Broek
Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands
Maaike W. van de Kamp, Kees Hendricksen & Bas W. G. van Rhijn
Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Thierry N. Boellaard
Department of Urological Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Richard P. Meijer
Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands
Antoine G. van der Heijden
Cancer Research UK Cambridge Institute, Cambridge, UK
Nitzan Rosenfeld
Cancer Research UK Major Centre Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK
Nitzan Rosenfeld
Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany
Bas W. G. van Rhijn

Authors

Jeroen van Dorp
View author publications
Search author on:PubMed Google Scholar
Christodoulos Pipinikas
View author publications
Search author on:PubMed Google Scholar
Britt B. M. Suelmann
View author publications
Search author on:PubMed Google Scholar
Niven Mehra
View author publications
Search author on:PubMed Google Scholar
Nick van Dijk
View author publications
Search author on:PubMed Google Scholar
Giovanni Marsico
View author publications
Search author on:PubMed Google Scholar
Maurits L. van Montfoort
View author publications
Search author on:PubMed Google Scholar
Sophie Hackinger
View author publications
Search author on:PubMed Google Scholar
Linde M. Braaf
View author publications
Search author on:PubMed Google Scholar
Tauanne Amarante
View author publications
Search author on:PubMed Google Scholar
Charlaine van Steenis
View author publications
Search author on:PubMed Google Scholar
Kirsten McLay
View author publications
Search author on:PubMed Google Scholar
Antonios Daletzakis
View author publications
Search author on:PubMed Google Scholar
Daan van den Broek
View author publications
Search author on:PubMed Google Scholar
Maaike W. van de Kamp
View author publications
Search author on:PubMed Google Scholar
Kees Hendricksen
View author publications
Search author on:PubMed Google Scholar
Jeantine M. de Feijter
View author publications
Search author on:PubMed Google Scholar
Thierry N. Boellaard
View author publications
Search author on:PubMed Google Scholar
Richard P. Meijer
View author publications
Search author on:PubMed Google Scholar
Antoine G. van der Heijden
View author publications
Search author on:PubMed Google Scholar
Nitzan Rosenfeld
View author publications
Search author on:PubMed Google Scholar
Bas W. G. van Rhijn
View author publications
Search author on:PubMed Google Scholar
Greg Jones
View author publications
Search author on:PubMed Google Scholar
Michiel S. van der Heijden
View author publications
Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Greg Jones or Michiel S. van der Heijden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Dorp, J., Pipinikas, C., Suelmann, B.B.M. et al. Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. Nat Med 30, 304 (2024). https://doi.org/10.1038/s41591-023-02500-7

Download citation

Published: 17 July 2023
Issue Date: January 2024
DOI: https://doi.org/10.1038/s41591-023-02500-7

This article is cited by

Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation
- Sia V. Lindskrog
- Trine Strandgaard
- Lars Dyrskjøt
Nature Reviews Urology (2025)
Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer
- Wei He
- Jiaxin Xie
- Shuxiong Zeng
Discover Oncology (2025)
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay
- Mitchell J. Elliott
- Philippe Echelard
- David W. Cescon
Nature Communications (2025)

Subjects

Author information

Authors and Affiliations

Corresponding authors

Rights and permissions

About this article

Cite this article

Share this article

This article is cited by

Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation

Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer

Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay

Search

Quick links